Biote Corp. announced on January 30, 2025, that Terry Weber will retire as Chief Executive Officer and step down from the company's Board of Directors, effective February 1, 2025. Ms. Weber will transition to a role as Strategic Advisor to the Board of Directors.
Concurrently, Bret Christensen has been appointed as the new Chief Executive Officer and a member of the Board of Directors, also effective February 1, 2025. This leadership change marks a new chapter for the company in its pursuit of personalized hormone optimization and therapeutic wellness solutions.
The transition aims to bring fresh leadership to guide Biote's strategic initiatives and operational execution. Mr. Christensen's experience is expected to contribute to the company's next phase of business growth and market expansion.
The content on BeyondSPX is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.